TrialPloS one2017

Efficacy and safety of sequential versus quadruple therapy as second-line treatment for helicobacter pylori infection-A randomized controlled trial.

Daniela Munteanu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.